Cargando…
Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential
Envenoming due to Loxosceles spider bites still remains a neglected disease of particular medical concern in the Americas. To date, there is no consensus for the treatment of envenomed patients, yet horse polyclonal antivenoms are usually infused to patients with identified severe medical conditions...
Autores principales: | Karim-Silva, Sabrina, Becker-Finco, Alessandra, Jiacomini, Isabella Gizzi, Boursin, Fanny, Leroy, Arnaud, Noiray, Magali, de Moura, Juliana, Aubrey, Nicolas, Billiald, Philippe, Alvarenga, Larissa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232456/ https://www.ncbi.nlm.nih.gov/pubmed/32316084 http://dx.doi.org/10.3390/toxins12040256 |
Ejemplares similares
-
Evaluation of the effects of Loxosceles intermedia’s venom in zebrafish
por: Tozzi, Ollavo Nogueira, et al.
Publicado: (2022) -
Exploration and Modulation of Antibody Fragment Biophysical Properties by Replacing the Framework Region Sequences
por: Cnudde, Thomas, et al.
Publicado: (2020) -
Engineering Venom’s Toxin-Neutralizing Antibody Fragments and Its Therapeutic Potential
por: Alvarenga, Larissa M., et al.
Publicado: (2014) -
Generation and characterization of monoclonal antibody against Advanced Glycation End Products in chronic kidney disease
por: Finco, Alessandra Becker, et al.
Publicado: (2016) -
TCTP from Loxosceles Intermedia (Brown Spider) Venom Contributes to the Allergic and Inflammatory Response of Cutaneous Loxoscelism
por: Boia-Ferreira, Marianna, et al.
Publicado: (2019)